T-NeuroDx Announces AlzheimerGuard™, a Novel Blood-Based Biomarker Assay for Early Detection of Alzheimer’s Disease
AlzheimerGuard is a proprietary blood-based biomarker assay designed to detect Alzheimer’s disease years before clinical symptoms appear. ALBUQUERQUE, NM, UNITED STATES, April 15, 2026 /EINPresswire.com/ -- T-NeuroDx, a biotechnology company focused on …